Benznidazole with CCNU: A clinical phase i toxicity study
Authors:
- J.T. RobertsJRJ.T. Roberts
- N.M. BleehenNBN.M. Bleehen
- 1 February 1985
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 11 (2) , 331-334
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A phase I study of the combination of benznidazole and CCNU in manInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1984
- Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humansBritish Journal of Cancer, 1983
- Chemosensitization by lipophilic nitroimidazolesBritish Journal of Cancer, 1983
- Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNUBritish Journal of Cancer, 1982
- The response of mouse lung tumors to combinations of CCNU and misonidazoleInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
- The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazolesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
- Enhancement of chemotherapy agentsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
- CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II studyCancer, 1973